Mygenia ONE Hereditary Cancers Panel
The ONE You Needed To Identify The Risks In Your Health Condition. Mygenia ONE hereditary cancers panel use advanced next-generation sequencing (NGS) technology. It can detect more than 200 type cancer-related genes by collecting only 6ml of blood with simple process, which provides a clear picture to show the risk
that you may have.
Send product info to my email
Why do we need cancer risk assessment?
Cancer has always ranked the number one killer worldwide and everyone knows that. However, not everyone knows that cancer can be predicted and prevented. Identifying the inheritance of cancer genes opens up chances for early preventive measures.
How is family history related to cancer?
Cancer is a common disease. There are many factors that trigger cells in becoming cancerous: aging, poor life style, poor diet, or pollution can all lead to cancer. Normally, people are born with the ability to repair and control damages caused by these factors. These natural abilities are coded in some specific genes known as the damage-controlling genes. Hereditary cancers occur when we born with one or more of these genes mutated. In other words, these cancer-causing gene mutations can be inherited.
Family history is important in determining the chance of inheritance. Everyone inherits two copies of the same gene from our parents, one from father and the other from mother. Most of the time, both inherited copies are normal. If one of the parents has a mutation in these genes, then it means that there is a 1 in 2 chance (50%) of inheriting the same mutation. Although, of all cancer cases, only about 10% are hereditary, it is still important to find out your hereditary risk so that early prevention can be made.
Mygenia ONE Screen Multiple Genes To Detect Multiple Cancer Risk
There are many factors that cause normal cells to become cancerous cells. For instance, aging, unhealthy lifestyles, bad eating habits, or environmental pollution may cause cancer. If a person is born with the mutation cancer genes, then these people are likely to suffer from hereditary cancer.
Mygenia ONE hereditary cancers panel use advanced next-generation sequencing (NGS) technology. It can detect more than 200 type cancer-related genes by collecting only 6ml of blood with simple process, which provides a clear picture to show the risk that you may have.
We can also find the most effective and most appropriate treatment for you. Doctor can also propose a target treatment programs based on the results. Precision Medicine is an emerging clinical medicine. It can establish personalized treatment according to the uniqued patient's genes, because all patients need different treatment. The emergence of target drugs make some of the cancer from terminally ill into a chronic disease that can control under long-term medication. If the disease cannot be cure, the patient can still has a longer survival time. The target drug will apply to patients according to genetic characteristics of the cancer cells.
How can Mygenia cancer panel test help you assess the cancer risk?
Mygenia cancer panel test covers 13 heritable cancer types:
Breast & Ovarian
Head & Neck
Patients can either choose to screen for all 13 cancer types (test code OFC) or 1 cancer type only (test code OF1). We also offer a follow up test for family members (test code OFF). This enables physicians in selecting the most optimal solution for the inherited cancer management as well as providing risk assessment for individuals with family history.
Medical consultation is included without additional charge.
- Free interpretation of test reports, analysis of genetic disease risk.
- Free assessment of the family's risk of the same genetic gene (if applicable)
We provide access to the latest in molecular diagnostic testing via the most advanced available technology for genetic screening and hereditary risk assessments.
Every minute counts when it comes to health,. Our fast turnaround times get you the comprehensive DNA data, results and analyses you need, quickly and efficiently.
We provide in-depth data analysis, specialist knowledge and valuable insights that enable you to provide the best possible care, recommendations and courses of treatment.
To complement our in-house expertise, we work closely with consulting specialist, Dr. Christopher Corless, to provide additional advice and analysis. An expert in surgical pathology and molecular diagnostics, Dr. Corless works from our partner lab, Knight Diagnostic Laboratories, a US-based global leader in genetic testing for solid tumours and hematopoietic malignancies.
Only 6ml blood sample is required for the genetic screening. Customer has sample collected in the listed clinics or at Pangenia office. The clinic will contact Customer to schedule report explanation by doctor after receiving the report from Pangenia. Alternatively, customer may receive the report by mail and call Pangenia hotline for inquiry about the result. Pangenia can also refer Customer to specified doctor/genetic counsellor to follow up.
Who should do the test?
- Multiple family members affected with the same cancer (eg. breast cancer) or related cancers (eg. breast and ovarian cancer, or colon and uterine cancer)
- Two or more first-degree relatives with rare tumors (eg. sarcoma in both a brother and a sister)
- Geographic or ethnic populations known to be at high risk of hereditary cancers (e.g., Ashkenazi Jews heritage and BRCA1 / BRCA2 mutations)
- Family history of unique tumor combinations (eg. sarcoma, breast and brain in the same family)
- Anyone in all ages who wants to identify the Cancer risk
- Each customer will entitle $200 PARKnSHOP Cash Voucher! First-come-first-served while stocks last.
- Breast Cancer
- Ovarian Cancer
- Lung Cancer
- Colorectal Cancer
- Stomach Cancer
- Prostate Cancer
- Kidney Cancer
- Pancreatic Cancer
- Liver Cancer
- Nervous system cancer
- Skin cancer
- Bone cancer
- Endocrine system cancer
- Head and Neck cancer
- Soft tissue cancer
- Hematopoiesis system cancer
Terms & Conditions
Terms and conditions of ordering the Mygenia assessment:
After successful payment, the Customer receives confirmation email from ESDlife. Pangenia will call the Customer to schedule the appointment within 1-3 working days. Customers can also arrange appointment by calling 39897211 after payment.
There are two options for the Customer:
- Customer has sample collected directly at Pangenia, where the sample will be analyzed. The report will be mailed to the address provided by the Customer. Customer may call Pangenia hotline for inquiry about the result. Pangenia is willing to refer Customer to specified doctor/genetic counsellor to follow up.
- Customer has sample collected in the listed clinics or at Pangenia office. The samples will be delivered to Pangenia for analysis. The clinic will contact Customer to schedule report explanation by doctor after receiving the report from Pangenia.
Customers must present their identity cards and the printed order confirmation letter on the appointment day.
Customers who purchase the Mygenia Hereditary screening with discounted price for 2 persons must present their DNA samples at the same day. Post-test consultation will be carried out for 2 persons at the same day.
The package is valid for 3 months (from the date of purchase) or it will be forfeited.
Report will be ready around 6 weeks and interpreted by medical and genetic professionals.
Amendment or cancellation is not allowed once the payment is confirmed.
The package cannot be transferred to a third party.
All tests are not for the purpose of medical diagnosis or treatment.
In case of dispute, ESDlife and Pangenia Lifesciences Limited reserve the right to make the final decision.
Disclaimer: ESDlife does not operate or provide the service above. ESDlife is irresponsible to any loss, injury or law action caused by using this plan. Any claims and inquiries should be addressed to Pangenia Lifesciences Limited.
Locations for sample collection:
1. Pangenia Lifesciences Ltd.
Floor 28, Tower A, Billion Centre, 1 Wang Kwong Road, Kowloon Bay, Hong Kong
2. Premier Clinic
19/F, Asia Standard Tower, 59 Queen's Road, Central, Hong Kong
3. Specialist in Family Medicine
3A, Shinyam Commercial Building, 163 Johnston Road, Wanchai, Hong Kong
Are you really as healthy as you think?
You may look healthy and fine today that serious diseases seem to be far away from you. However, have you ever thought that threatening diseases are lurking deep within your body?
Genes inherited from the previous generation, not only will affect your physical appearance, but also secretly buried a lot of risk factors for your health status.Nowadays scientific researches confirmed that many diseases are actually related to your genes, such as cancer and sudden death caused by heart diseases.
However, the incidence of genetic diseases can actually be effectively reduced by proper precautions. An early understanding of your own genes can keep you away from genetic diseases.
Who should be assessed?
Pangenia recommends that all people should be assessed, especially those with family history of genetic diseases. People who worry that they will suffer from genetic diseases should carry out a comprehensive health assessment of the genes. Genetic diseases are often hidden, but they can trigger life-threatening situations in a sudden. Therefore, you are advised to take preventive measures early to understand your genetic status.
What is Mygenia ONE? Is it reliable?
The Mygenia ONE Health Risk Assessment examines the state of genes associated with inherited diseases in your blood sample using a new generation of gene sequencing technology.
Pangenia professional team looks at your genetic information and refers to an internationally recognized gene database to determine if your gene has pathogenic variations and report to you.
Mygenia ONE uses the most advanced new-generation gene sequencer in Hong Kong to process the test for you. The PANGENIA scientific team is trustworthy that 30 % of the professionals have a doctorate in addition to the medical laboratory technician recognized qualifications.
What will I get after the test?
After detailed analysis of the relevant genes, Pangenia team of professional laboratory technicians will report your gene profile based on the latest gene database, and list out the relationship between the gene variations and the related diseases. Your doctor can help you choose the most appropriate precautions.
How long is my report valid?
Genetic variations remain unchanged throughout your lifetime. In addition, we will provide you with a report review service to ensure the maximum protection for you. As long as you have received a Mygenia ONE health risk assessment, you can apply for periodic updates to your report. Our scientific team will update you on the latest information about the diseases and the corresponding genes in the genetic database. As a result, your reports will continue to be valid.
How should I conduct the test?
Please contact and consult your doctor first. Your doctor will take 6 ml of blood, along with the completed test application form and then send it to PANGENIA's laboratory for testing. You will receive your report within 6 weeks.
Hereditary cancer health risk assessment
Why do I need to do a genetic cancer health risk assessment?
There are many factors that cause normal cells to become cancerous. For example, aging, unhealthy lifestyles, poor eating habits, or even environmental pollution can cause cancer. If a person is born with mutations in cancer genes, they are more likely to suffer from hereditary cancer induced by environmental factors.
How does genetic cancer health risk assessment help me?
Mygenia ONE genetic cancer health risk assessment uses advanced next-generation gene sequencing system (NGS). The process is simple that it only requires 6ml of blood sample. This test is comprehensive that it can screen more than 200 cancer-related genes to let you understand the risk of cancer.
Doctors can design a targeted treatment programs for your based on the test results.
Precision medicine is an emerging approach for disease treatment. Personalized treatment can be designed by targeting the patients’ unique genetic profile. Every patient needs different treatment. Targeted therapy enables the treatment of cancers which have once been thought as untreatable, extending the life-span of patients.
The Mygenia CANCER genetic cancer health risk assessment covers the most common genetic disorders as follow:
Head and neck cancer
Gastric cancer and kidney cancer
Pancreatic cancer and cholangiocarcinoma
Colon cancer, small intestine cancer and colorectal cancer
Soft tissue sarcoma
Primary peritoneal cancer
Fallopian tube cancer